Tagged with Artificial Intelligence

Lars Bo Nielsen – Director General, Danish Medicines Agency (DKMA)
Adopting AI in Pharma: Start with the Problem, Not the Technology
Saskia Steinacker – Senior Vice President, Global Head Strategy and Digital Transformation (IT), Bayer
4 Key Insights for Pharma and Healthcare from Davos 2024
3 Essential Characteristics for AI Impact in Clinical Research
EU Acts on the Promise of Artificial Intelligence for Medicinal Products
Alex Zhavoronkov – Founder & CEO, Insilico Medicine
Betting the Bottom Dollar on AI in Pricing & Market Access
Four Insights from Amgen CEO Bob Bradway
Hugo F. Villegas – SVP & President, Canada & Latin America, Medtronic
Artificial Intelligence Can Save Pharmacovigilance in Australia
PharmaBoardroom’s Top Five Op-Eds of 2021
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here